Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Registrati

Quotazioni in diretta

BAX Baxter International Inc

29,50

0,60 (2,08%)

21 Dic 2024 - Chiuso

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/13/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ BRIAN STEVENS

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Baxter (NYSE:BAX)
Storico
Da Nov 2024 a Dic 2024

Clicca qui per i Grafici di Baxter

Grafico Azioni Baxter (NYSE:BAX)
Storico
Da Dic 2023 a Dic 2024

Clicca qui per i Grafici di Baxter

Notizie Baxter International Inc - BAX

Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference
Mercoledì 18 Dicembre 2024 (2 giorni fa) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 17 Dicembre 2024 (3 giorni fa) • Edgar (US Regulatory)

Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S.
Mercoledì 11 Dicembre 2024 (1 settimana fa) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 4 Dicembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 4 Dicembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 4 Dicembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 8-K - Current report
Mercoledì 27 Novembre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 8-K - Current report
Venerdì 22 Novembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Baxter to Present at 7th Annual Evercore HealthCONx Conference
Martedì 19 Novembre 2024 (1 mese fa) • Business Wire

Baxter to Present at Jefferies London Healthcare Conference
Mercoledì 13 Novembre 2024 (1 mese fa) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mercoledì 13 Novembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Martedì 12 Novembre 2024 (1 mese fa) • Edgar (US Regulatory)

Più Baxter International Inc Articoli Notizie

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea